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Background. Although the prevalence of work-limiting diseases is increasing, the interplay between occupational exposures and
chronic medical conditions remains largely uncharacterized. Research has shown the detrimental effects of workplace bullying
but very little is known about the humanistic and productivity cost in victims with chronic illnesses. We sought to assess work
productivity losses and health disutility associated with bullying among subjects with chronic medical conditions. Methods.
Participants (𝑁 = 1717) with chronic diseases answered a self-administered survey including sociodemographic and clinical data,
workplace bullying experience, the SF-12 questionnaire, and theWork Productivity Activity Impairment questionnaire. Results.The
prevalence of significant impairment was higher among victims of workplace bullying as compared to nonvictims (SF-12 PCS: 55.5%
versus 67.9%, 𝑝 < 0.01; SF-12 MCS: 59.4% versus 74.3%, 𝑝 < 0.01). The adjusted marginal overall productivity cost of workplace
bullying ranged from 13.9% to 17.4%, corresponding to Italian Purchase Power Parity (PPP) 2010 US$ 4182–5236 yearly. Association
estimates were independent and not moderated by concurrent medical conditions. Conclusions. Our findings demonstrate that the
burden on workers’ quality of life and productivity associated with workplace bullying is substantial. This study provides key data
to inform policy-making and prioritize occupational health interventions.
1. Introduction
All developed countries are facing a sustained shift in the
demographic composition of their population and are thus
devoting major effort to increasing the work participation
rate of aging and disabled people [1]. Together with long-
term health problems and chronic diseases, prevalence of
work-limiting disabilities increases with age [2]: it has been
estimated that 72% of all-causes Disability-Adjusted Life
Years occur in subjects under 60 years old and more than
three-quarters of old workers have at least one chronic health
condition that requires management [3, 4]. In addition, the
majority of workers with chronic illnesses continue to work
and have to deal with several workplace risk factors [5, 6].
However, the interplay between occupational exposures and
chronic medical conditions remains largely uncharacterized,
thus limiting the potential for effective preventive and thera-
peutic actions.
Workplace bullying is a common and severe occupational
stressor and imbalance of power, harm, and systematic rep-
etition over time represent its key elements [7]. The adverse
effects of workplace bullying on victims’ psychological health
span from mild anxiety and depression to severe posttrau-
matic stress symptoms [8–14]. Similarly, workplace bullying
also has a detrimental impact on organizational outcomes,
such as job satisfaction, organizational commitment, and
intention to leave [15, 16].
Despite evidence showing that workplace bullying may
be associated with a significant financial burden for victims
and organizations, cost estimates are difficult to compare
due to different currencies, methodologies, time frames,
and the selection of different cost drivers (e.g., health care
cost, productivity and performance loss, sick leave, and
replacement costs) [17].
Research has shown that having a disability is a risk factor
for being bullied [18–21] and there is some evidence showing
longitudinal associations between mental health problems
and subsequent exposure to bullying at work [22–25]. Targets
of workplace bullying with preexisting chronic diseases could
experience worse consequences and perceive themselves as
being bullied more frequently compared to colleagues with
no other medical conditions [12, 26]. Furthermore, exposure
to psychosocial stressors at work may play an important role
in retirement behavior and labor supply decisions among
workers with chronic diseases [27, 28].
Although psychosocial factors and chronic conditions are
both emerging issues in occupational medicine, very little
is known about the humanistic and productivity cost of
bullying at work in workers with chronic illness. Empirical
research would help health authorities and employers pri-
oritize the allocation of limited resources for occupational
health interventions [29]. As a consequence, the assessment
of health-related quality of life and cost-effectiveness analyses
are gaining importance in occupational medicine because
decision-makers need comparable and accurate information
in order to achieve the greatest health improvement for
their workforce. In the present study, we sought to evaluate
work productivity losses and health disutility associated with
workplace bullying among patients with different chronic
medical conditions.
2. Materials and Methods
2.1. Participants and Procedures. The present study is a
joint analysis of the Liberamente and MOSAICO research
datasets. Both studies aimed at evaluating the quality of life,
treatment satisfaction, social participation, and health care
utilization of patients with commonmedical conditions such
as major depression disorder (Liberamente study), inflam-
matory bowel disease, psoriasis and autoimmune arthritis
(MOSAICO study).
The Liberamente study was carried out between June and
July 2013 in 18 outpatient referral centers for diagnosis and
treatment of psychiatric disorders across all Italian regions.
Patients referred to the centers for psychiatric conditions
were screened for eligibility by a psychiatrist during a regular
follow-up visit at the clinic. We included adult patients with a
clinical diagnosis of depression (i.e., recurrent depressive dis-
order, major depressive episode, adjustment disorder, mixed
affective disorder, dysthymia, and other persistent depressive
disorders) with the exclusion of bipolar disorders. Seven hun-
dred patients agreed to participate in the research completing
an anonymous self-administered paper-and-pencil question-
naire. Concurrently, the same psychiatrist recorded relevant
clinical characteristics in a standardized data collection form.
To preserve anonymity of data collection while matching
clinical and patient-reported information, the psychiatrist
handed the data collection form to the patient at the end of the
visit.Thepatients sealed both the data collection form and the
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self-administered questionnaire in an anonymous envelope
to return to the research team.
The MOSAICO study was carried out between April and
October 2014. We invited the members of Patients’ Asso-
ciations for people with Crohn’s Disease, ulcerative colitis,
psoriasis, ankylosing spondylitis, rheumatoid arthritis, and
psoriatic arthritis to take part in the study. The survey
adopted a dual methodology. A web survey was posted on
the associations’ web sites. Respondents were 143 registered
patients with autoimmune arthritis, 397 patients with inflam-
matory bowel disease, and 236 patients with psoriasis. All
participants accessed the survey from their personal account.
Additionally, 152, 52, and 37 patientswith autoimmune arthri-
tis, inflammatory bowel disease, and psoriasis, respectively,
elected to complete a self-administered paper-and-pencil
version of the survey.
2.2. Measures. Surveys included sociodemographic and
occupational information, the Work Productivity and Activ-
ity Impairment scale, and the SF-12v1 (RAND).
2.2.1. Workplace Bullying. Research has essentially used two
methodologies to assess workplace bullying: (i) investigating
subjects’ perceptions of victimization (self-labelling method)
and/or (ii) their exposure to specific bullying behaviors
(behavioral experience method) [30]. In this study, work-
place bullying was measured using the self-labelling method
by providing respondents with a theoretical definition of
workplace bullying (“bullying takes place when one or more
persons systematically and over time feel that they have
been subjected to negative treatment on the part of one or
more persons, in a situation in which the person(s) exposed
to the treatment have difficulty in defending themselves
against them. It is not bullying when two equally strong
opponents are in conflict with each other” [31, pages 190-191]).
Participants responded to a single-item question (“according
to this definition have you been subjected to bullying at the
workplace during the last six months?”) using a five-point
scale from 1 (never) to 5 (yes, many times a week). Subjects
reporting a frequency of bullying of 3 or above on the five-
point scale were considered victims of workplace bullying
for the purpose of this analysis. In addition, the length of
time for which workplace bullying had been experienced was
assessed.
2.2.2. Outcomes
Health-Related Quality of Life. The SF-12 questionnaire
(RAND, [32]) is a 12-item generic health profile measure
assessing patients’ perception of their own mental and
physical health. Ratings use a 0–100-point scale. A 𝑡-score
calculated on the normative values of the Italian general
population is obtained from raw scores. Patients reporting
scores lower than 42.0 and 43.85 on the SF-12 mental and
physical composites, respectively, were classified as signifi-
cantly impaired [33, 34].
Health Utility. The SD-6D utility index represents the
value assigned to a specific health status characterized by
the impairments, functional states, perceptions, and social
opportunities that are influenced by disease, injury, treat-
ment, or policy. The scoring algorithm of the Short Form 6
Dimension (SF-6D) is a two-step process: in the first step,
responses to SF-12 questions are used to define a response
vector representing the patient’s health state (classification
system); then, in the second step, the vector is converted into
a utility value using a utility function obtained from a sample
of the general population. The SF-6D classification system
includes six multilevel dimensions (physical functioning,
role of participation, social functioning, bodily pain, mental
health, and vitality) and describes 18,000 health states [35].
The SF-6D utility index was calculated according to the
utility function observed by Brazier et al. [35] using standard
gamble experiments carried out in a sample of the general
population. Scale ratings range from 0 (death) to 1 (perfect
health).
Productivity Loss. Economic evaluations conducted from an
employer’s perspective express the benefit of occupational
health interventions in terms of health-related productivity,
which is translated into a monetary value and may also be
referred to as an indirect cost [29]. The Work Productivity
Activity Impairment questionnaire [36] consists of 4 items:
(Q1) hours lost due to health problems; (Q2) hours lost due
to any other reason; (Q3) hours actually worked; and (Q4)
the degree of which health problems affected productivity
while at work. Responses ranged from 0 (“My health problem
had no effect on my work”) to 10 (“My health problem
completely preventedme fromworking”). Estimationmetrics
were calculated as percentage productivity losses, with higher
values indicating a greater proportion of time lost at work
(less productivity). The following equations were calculated.
Equation for sick leave is as follows:
[
Q1
(Q1 +Q3)
] ∗ 100. (1)
Equation for work impairment while at work or presen-
teeism is as follows:
Q4 ∗ 10. (2)
Equation for overall work productivity loss is as follows:
{SickLeave + [(1 − SickLeave) ∗ Presenteeism]}
∗ 100.
(3)
Percentage productivity losses were converted to the cor-
responding share of the Italian Purchase Power Parity (PPP)
per capita Gross Domestic Product (2010, US$ 31,090) [37]
which allows cross-national comparisons. PPP represents the
real exchange rate (nominal exchange rate adjusted for the
price index), that is, how much money would be needed
to purchase the same goods and services in two different
countries.
2.2.3. Demographic Information. Surveys included a section
on sociodemographic characteristics. We recorded patients’
age, gender, education level, marital status, employment
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Table 1: Characteristics of study sample across different chronic diseases. 𝑝 values represent significant levels of 𝜒2 for categorical variables,
one-way ANOVA for continuous variables.
Total
(𝑁 = 1717)
AA
(𝑁 = 295)
IBD
(𝑁 = 449)
MDD
(𝑁 = 700)
PSO
(𝑁 = 273) 𝑝
𝑛 (%) 𝑛 (%) 𝑛 (%) 𝑛 (%) 𝑛 (%)
Women (𝑁 = 1586)∗ 978 (61.7) 172 (72.9) 243 (57.5) 436 (65.2) 127 (49.2) <0.0001
Family (𝑁 = 1592)∗ 969 (60.9) 170 (72.0) 240 (56.7) 376 (55.7) 183 (71.0) <0.0001
University education (𝑁 = 1589)∗ 315 (19.8) 45 (19.1) 78 (18.4) 116 (17.3) 76 (29.5) 0.0004
Employment (𝑁 = 1603)∗ <0.0001
Employed 897 (56.0) 129 (54.7) 268 (63.4) 334 (48.7) 166 (64.3)
Inactive 293 (18.3) 20 (8.5) 62 (14.7) 177 (25.8) 34 (13.2)
Retired 183 (11.4) 67 (28.4) 43 (10.2) 60 (8.75) 13 (5.04)
Unemployed 230 (14.3) 20 (8.47) 50 (11.8) 115 (16.8) 45 (17.4)
Contract (𝑁 = 1591)∗ <0.0001
Temporary 128 (8.05) 12 (5.17) 35 (8.29) 62 (9.13) 19 (7.36)
Permanent 606 (38.1) 90 (38.8) 178 (42.2) 219 (32.3) 119 (46.1)
Self-employed/employer 151 (9.49) 23 (9.91) 54 (12.8) 46 (6.77) 28 (10.8)
Job demand (WAI) (𝑁 = 882)∗ <0.0001
Physical demand 80 (9.07) 4 (3.17) 17 (6.37) 47 (14.6) 12 (7.23)
Mental demand 416 (47.2) 56 (44.4) 121 (45.3) 139 (43.0) 100 (60.2)
Mixed demand 386 (43.8) 66 (52.4) 129 (48.3) 137 (42.4) 54 (32.5)
Mean (sd) Mean (sd) Mean (sd) Mean (sd) Mean (sd) p
Age (𝑁 = 1603)∗ 46.8 (13.1) 48.8 (10.4) 42.0 (12.2) 46.1 (10.9) 44.1 (8.79) <0.0001
Workforce (𝑁 = 1717)∗ 1603 (93.4) 236 (80.0) 423 (94.2) 686 (98.0) 258 (94.5) <0.0001
Time since diagnosis (years) (𝑁 = 1593)∗ 10.4 (10.2) 13.3 (10.1) 12.4 (9.45) 5.89 (7.38) 12.5 (11.5) <0.0001
Hospitalization (days) (𝑁 = 1593)∗ 2.37 (8.38) 1.90 (7.00) 3.50 (10.9) 2.55 (8.51) 0.72 (2.79) 0.0004
∗Number of valued cases for each variable.
status, employment contract, and preeminent job demand
(either physical, mental, or mixed) with items from theWork
Ability Index (WAI, [38]). Workforce status was defined
based on patients’ age (between 18 and 65 years). We classi-
fied employment, inactivity, retirement, and unemployment
status using the International Labour Office definition [39].
Common medical information in both datasets included the
number of days of hospitalization in the past 12 months, time
since chronic disease onset (years), and chronic condition
type (major depression disorder (MDD), autoimmune arthri-
tis (AA), psoriasis (PSO), and inflammatory bowel disease
(IBD)). We used number of days of hospitalization rather
than overall health care utilization rates (i.e., outpatients
visits, mental health services) as a proxy of chronic disease
severity to minimize the information bias due to the inability
to discern between bullying-related medical encounters and
those caused by the cooccurring chronic medical condition.
2.3. Analysis. We computedmeans and standard deviation or
absolute and relative frequency of continuous and categorical
variables, respectively. We evaluated differences in sociode-
mographic and clinical characteristics across diagnosis status
with 𝜒2 or one-way ANOVA as appropriate. Unadjusted
and adjusted quality-of-life penalty, health disutility, and
productivity losses associated with workplace bullying were
estimated with generalized linear models. To account for the
skewed distribution of outcomes, we fitted OLS regressions
with log link function in the analysis of SF-12 and SF-
6D scores. Additionally, we fitted gamma regressions for
the analysis of lost productivity time (WPAI metrics). All
models were adjusted for patients’ age, gender, education,
marital status, job demand, contract, hospitalization days,
diagnosis, time since disease onset, and time since the onset
of workplace bullying.We also tested the interaction between
chronic disease and self-reported bullying experience in all
models. 𝑝 < 0.05 was considered statistically significant.
Analyses were conducted with SAS 9.2.
3. Results
3.1. Sample Characteristics. Demographic and clinical char-
acteristics of the sample are summarized in Table 1. Although
the majority of subjects were of working age (46.8 ± 13.1),
only 56% of the sample were actually employed. Participants
with a paid job were more likely to be men (63.7% versus
51.3%, 𝑝 < 0.01), were slightly younger (44.0 ± 9.8 versus
46.3 ± 12.5, 𝑝 < 0.01), reported less hospitalization days
(1.8 ± 6.5 versus 3.2 ± 10.4, 𝑝 < 0.01), and were more
likely to have tertiary qualifications (24.7% versus 13.6%,
𝑝 < 0.01). Among subgroups, significant differences were
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Table 2: Sample characteristics across workplace bullying status. 𝑝 values represent significant levels of 𝜒2 for categorical variables, one-way
ANOVA for continuous variables.
No workplace bullying
𝑁 = 632 (83.7%)
𝑛 (%)
Workplace bullying
𝑁 = 123 (16.3%)
𝑛 (%)
𝑝
Women 367 (58.6) 68 (56.7) ns
Married or de facto 392 (62.2) 67 (54.9) ns
University education 154 (24.5) 22 (18.0) ns
Job security 520 (84.1) 98 (15.9) ns
Job demand ns
Physical dem. 59 (86.8) 9 (13.2)
Mental dem. 303 (85.1) 53 (14.9)
Mixed dem. 261 (81.6) 59 (18.4)
Mean (sd) Mean (sd) p
Age 44.6 (10.9) 47.2 (12.3) 0.02
Time since diagnosis (years) 9.89 (9.71) 10.0 (9.97) ns
Hospitalization (days) 1.61 (5.83) 1.88 (4.46) ns
seen in employment status: subjects with MDD and PSO
reported, respectively, the highest percentage of inactivity
(25.8%) and unemployment (17.4%), while 28.4% of patients
with AA were retired. In most subgroups, there was greater
representation of women and the overall prevalence of jobs
with considerable physical demands was quite low. Apart
from MDD, with most subjects reporting a more recent
diagnosis (5.89 ± 7.38), most other chronic diseases had been
affecting participants for a long time (12.4 to 13.3 years).
3.2. Prevalence of Workplace Bullying. Table 2 shows the
prevalence of workplace bullying in the whole sample. One
hundred and twenty-three subjects (16.3%) labelled them-
selves as victims of bullying at work. Bullied subjects were
slightly older (44.6 ± 10.9 versus 47.2 ± 12.3; 𝑝 = 0.02).
No statistically significant differences were found in bullying
prevalence across the different chronic diseases (AA 16.2%,
IBD 15.4%, MDD 17.6%, and PSO 15.1%, 𝑝 = 0.89).
Eighty-one percent of bullied subjects had a preexistent
medical condition before bullying onset. However, in the
subgroup of patientswithMDD, 30% reported thatworkplace
bullying had occurred before the onset of depression.
3.3. Workplace Bullying and Productivity Losses. The mean
average weekly full-time equivalent sick hours were 6.58
± 11.92, and corresponding average sick-leave rate was
16.4% ± 29.8. Work impairment was 41.9% ± 31.6, whereas
the overall productivity loss (absenteeism + presenteeism)
was 46.5% ± 33.2. Unadjusted productivity losses due to
sick leave and presenteeism were both associated with work-
place bullying (Figure 1(a), 𝑝 < 0.001). These associations
were both robust to adjustment for possible confounders
(Figure 1(b), 𝑝 < 0.001) and were not moderated by
disease status (𝑝 for interactions with diagnosis >0.05). The
relative risk of sick leave associated with workplace bullying
was 1.86 (95% CI: 1.30–2.82). This estimate was robust to
adjustment for age, gender, education, chronic disease status,
and contract type (temporary/long-term contract). Among
hypothesized confounders, only days of hospitalizations were
associated with productivity losses (Table 3). The adjusted
marginal overall productivity cost of workplace bullying
ranged from 13.9% (IBD) to 17.4% (PSO), corresponding to
PPP 2010US$ 4182–5236 yearly.
3.4. Workplace Bullying and Health-Related Quality of Life.
The average scores of quality of life were 41.9 ± 10.6, 39.8 ±
11.3, and 0.664 ± 0.102 for the SF-12 PCS, SF-12 MCS, and SF-
6D indexes, respectively. Among employed patients, 56.7%
and 57.0% reported significant impairment as defined by the
SF-12 PCS and SF-12 MCS scales, respectively. Workers who
self-reported bullying at work were more likely classified as
significantly impaired on both scales compared to nonvictims
(SF-12 PCS: 55.5% versus 67.9%, 𝑝 < 0.01; SF-12 MCS:
59.4% versus 74.3%, 𝑝 < 0.01). Unadjusted health-related
quality-of-life scores were associated with workplace bullying
(Figure 2(a), 𝑝 < 0.001). These associations were both
robust to adjustment for possible confounders (Figure 2(b),
𝑝 < 0.001) and were not moderated by disease status (𝑝
for interactions with diagnosis >0.05).The adjusted marginal
disutility associated with workplace bullying ranged from
0.048 (AA) to 0.052 (PSO). Figure 3 illustrates unadjusted SF-
6D scores of workers who self-reported workplace bullying
as compared to those who had not experienced workplace
bullying.
Additionally, health-related quality-of-life scores were
associated with days of hospitalization, gender, marital status,
education, job security, and diagnosis (Table 3).
4. Discussion
4.1. Prevalence of Workplace Bullying. In this large multi-
center cross-sectional study among workers with common
chronic conditions [40–43], the prevalence of workplace
bullying was 16% and most workplace bullying started after
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Figure 1: Work productivity losses across workplace bullying status among workers with different chronic conditions. (a) Unadjusted scores.
(b) Adjusted scores. Models included age, gender, time since diagnosis, time since workplace bullying onset, education, marital status, job
demand, contract, diagnosis, and hospitalization days.
the onset of chronic disease. There is wide variation in
prevalence estimates of workplace bullying across studies.
Italian rates in the general working population range from
4.8% in a public service organization to 31.4% among airport
employees [44]. Other prevalence studies have found rates of
3.5% in Sweden up to 27% in North America [45, 46]. These
discrepancies are partially explained by different methods of
measurement and criteria used to define workplace bullying
[30, 47, 48].
4.2. Workplace Bullying and Productivity Loss. We observed
a significant association between workplace bullying and all
components of productivity. Workers who were not self-
labelled as victims of workplace bullying showed WPAI
scores similar to previous findings among patients with the
samemedical conditions [49–52]. However, participants who
self-reported workplace bullying showedmuch higherWPAI
scores. Our estimates suggest that the potential economic
impact of preventive or therapeutic interventions addressing
workplace bullying on yearly overall productivity loss might
range from about PPP 2010US$ 4200 to 5200 for each case
prevented. Although cost-of-illness studies provide valuable
information on the overall burden of disease, they generally
lead to unrealistic expectations about savings from therapy as
current treatments may reduce symptoms but are unable to
eradicate the disease. Conversely, several effective interven-
tions can be implemented at different levels to prevent and
manage workplace bullying (e.g., antibullying policy, code
of conduct, psychosocial risk analysis, and training) [53].
Coupled with the huge impact on overall productivity loss,
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Table 3: Significant association estimates (𝛼 < 5%) between workers sociodemographic and clinical characteristics and study outcomes.
Estimates represent the change score in outcome for each unit change in the independent variables. Models included age, gender, time since
diagnosis, time since workplace bullying onset, education, marital status, job demand, contract, diagnosis, and hospitalization days.
Impairment Sick leave Total productivity loss SF-12 PCS SF-12 MCS SF-6D index
Hospitalization (days) 0.027∗ 0.055∗∗∗ 0.025∗ −0.012∗∗∗ −0.007∗∗ −0.005∗∗∗
Men ns ns ns 0.069∗∗∗ ns 0.040∗∗∗
Living alone ns ns ns ns −0.060∗∗ ns
High school or lower ns ns ns ns ns −0.028∗
Temporary work ns ns ns ns −0.057∗ ns
Diagnosis
AA ns ns ns −0.208∗∗∗ ns −0.073∗∗∗
IBD ns ns ns −0.088∗∗∗ ns −0.052∗∗
MDD ns ns ns −0.066∗∗ −0.139∗∗∗ −0.043∗∗
PSO — — — — — —
∗
𝑝 < 0.05; ∗∗𝑝 < 0.01; ∗∗∗𝑝 < 0.001.
workplace bullying should be considered an overriding issue
for public health authorities and employers alike. Although
our study cannot demonstrate causality of association, our
findings help compare competing hypothetical scenarios to
prioritize research investments. Our results demonstrate a
strong association between sick-leave rates and exposure to
workplace bullying. Nonetheless, previous studies have found
relatively weak relationships between workplace bullying
and absenteeism [15, 16]. This might be explained by the
observation that victims of bullying may enhance their effort
and commitment when their work performance and self-
esteem are impaired [54]. Such compensative mechanism
might not offset detrimental effects of bullying among victims
with concurrent chronic health conditions due to the greater
severity of their psychological and psychosomatic complaints
[12].
Additionally, contrary to the short reference time adopted
in this study (e.g., self-reported hours lost in the past week),
most of the previous studies based their estimates on sick-
leave events registered in administrative databases or adopted
coarse self-reported measures (i.e., ever taken any sick leave
due to workplace bullying) which may lead to information
bias [26, 55, 56]. For example, as data repositories serve work-
compensation procedures, their capture rate may be limited
to eventswhose duration is eligible for compensation. For this
reason, estimates from previous studies may underestimate
the real productivity burden of workplace bullying. Consis-
tent with labor supply models, there is empirical evidence
suggesting that long-term sick leave is not an expression of
withdrawal behaviors such as lateness, shorter sick leave, or
reduced performance at work; on the contrary, longer spells
aremore frequently associatedwith serious illness rather than
reduced commitment and motivation [57, 58]. Consistent
with previous studies demonstrating the relationship between
incivility at work and withdrawal behavior [59], we showed
that workplace bullying is associatedwith reduced attendance
(i.e., either lateness or sick days) beyond the effect of concur-
rent disabling medical conditions.
4.3. Workplace Bullying and Health-Related Quality of Life. A
further important finding of our study was that workplace
bullying was associated with worse health-related quality-of-
life scores above and beyond the detrimental effect of other
concurrentmedical conditions.There is sparse evidence from
previous studies that exposure to occupational psychosocial
strain is associated with reduced health-related quality of life
[60–63]. To our knowledge, this is the first study assessing the
association between workplace bullying and health-related
quality of life. The workplace bullying penalty observed in
our study was clinically significant for the SF-12 PCS, SF-12
MCS, and SF-6D index according to the proposed thresholds
for the minimal clinically important difference for HRQOL
[64]. Additionally, the overall effect size observed in our
study was similar to the SF-12 physical composite (Cohen’s
𝑑 = 0.42) compared to the SF-12 mental composite (Cohen’s
𝑑 = 0.47). Of note, victims of workplace bullying were more
likely classified as significantly impaired on both SF-12 scales.
The cut-off chosen represents the lowest octile of the score
distribution in working populations and indicates a severely
compromised function.
The overall effect size observed for the SF-6D index was
moderate (𝑑 = 0.57): the adjusted disutility associated with
workplace bullying corresponded to 18-19 days of healthy
life lost for each year spent with the condition. The SF-6D
scores reported by patients who were not self-labelled as
victims of workplace bullying were comparable to figures
reported in previous studies among subjects with the same
medical condition (Figure 3) [65–69]. Exposure to workplace
bullying is associated with posttraumatic stress reactions,
anxiety, depression, and insomnia as well as chronic fatigue,
psychosomatic symptoms,musculoskeletal and gastrointesti-
nal disorders, headaches, and hypertension [8, 9, 12–14].
4.4. Strengths and Limitation. This study has several
strengths. First, we evaluated the burden of workplace
bullying on important outcomes among underresearched
groups with different diseases. Second, we complied with
recommendations for reporting economic evaluations in
occupationalmedicine [29]. For example, in order to improve
comparability and interpretability of our findings and to
minimize the likelihood of underestimation, we adopted
a widely used questionnaire, and we identified the source
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Figure 2: Health-related quality of life across workplace bullying status among workers with different chronic conditions. (a) Unadjusted
scores. (b) Adjusted scores. Models included age, gender, time since diagnosis, time since workplace bullying onset, education, marital status,
job demand, contract, diagnosis, and hospitalization days.
of price weights used and reported percent productivity
loss for all components of indirect costs from the employer
perspective [70]. By converting such findings into a financial
metric, we sought to help organizational and public health
stakeholders to better translate the impact of workplace
bullying for people with chronic medical conditions. Third,
our large sample size permitted adjustment for potentially
important confounders thus reducing the likelihood of bias.
Finally, community-based data on work productivity from a
clinical population may present lesser degree of desirability
bias compared to surveys conducted in occupational settings.
However, we must acknowledge some limitations. We
relied on a self-labelling measure of workplace bullying, the
most commonly adopted in epidemiological studies [48],
whichmight have introduced information bias.Howdifferent
estimation methods and measurements affect findings is
still underinvestigated [30]. We primed participants with a
widely accepted theoretic definition of workplace bullying to
improve the accuracy of their subjective evaluation of vic-
timization and power imbalance given the complexity of the
phenomenon and potential for misinterpretation. Typically
prevalence estimates yielded with the self-labelling approach
are lower than those based on behavioral experiencemethods
[47], so we used a broad cut-off for frequency of bullying
experience (“now and then” to “many times a week”). Addi-
tionally, cross-sectional studies cannot prove causality since
BioMed Research International 9
0.76
0.67
0.68
0.63
0.63
0.65
0.58
0.73
0.74
0.60
0.68
0.66
0.63
0.26 0.36 0.46 0.56 0.66 0.76 0.86
General population
MDD
MDD-no workplace bullying
MDD-workplace bullying
Rheumatoid arthritis
AA-no workplace bullying
AA-workplace bullying
PSO
PSO-no workplace bullying
PSO-workplace bullying
IBD
IBD-no workplace bullying
IBD-workplace bullying
Figure 3: SF-6D scores in workers self-labelled as victims compared to those not reporting workplace bullying across different chronic
diseases. Results from previous studies are reported for comparison [65–69].
a necessary criterion of causation is the appropriate temporal
relationship between the hypothesized risk factors and out-
comes. Finally, we do not have information concerning the
attrition rate of both studies. As a consequence, we cannot
exclude the notion that selection bias may have occurred.
However, the consistency of productivity loss and quality-of-
life estimates found in our study with those published in the
literature [49–52, 65–69] supports the validity of our results.
Future studies could collect data to assess psychosocial
risk factors which may influence the associations observed.
Although we did not observe any interaction between disease
status and workplace bullying (i.e., the burden of bullying is
consistent across different disease populations), our results
may not be generalized to all workers with chronic con-
ditions. Further studies could evaluate the humanistic and
indirect burden of victimization at work among patients
with an expanded range of chronic medical conditions (e.g.,
cardiovascular disease, diabetes, and chronic obstructive
pulmonary disease).
5. Conclusions
Our findings demonstrate that the burden of workplace bul-
lying on quality of life and productivity is substantial among
workers with common and severe chronic diseases. These
associations were independent of the underlying medical
conditions (psoriasis, autoimmune arthritis, inflammatory
bowel syndrome, and depression). This study provides key
data to inform policy-making and prioritization of occupa-
tional health interventions.
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